Literature DB >> 1983284

The immune response to mycobacterial heat shock proteins.

D B Young1.   

Abstract

Several prominent protein antigens involved in antibody and T cell responses to mycobacteria have been identified as members of highly conserved heat shock protein families. The immunogenicity of heat shock proteins in a broad range of infections, along with the extensive sequence identity between corresponding host and pathogen homologues, and the potential for localized accumulation in response to stress stimuli, makes these antigens attractive candidates for theories of autoimmunity based on "molecular mimicry". The 65 kilodalton (kD) heat shock protein of mycobacteria has indeed been shown to modulate the course of autoimmune disease in experimental animals, and immune responses to this and other heat shock proteins have been demonstrated in association with human autoimmune diseases. This paper provides a brief review of the immune response to mycobacterial heat shock proteins during infection and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1983284     DOI: 10.3109/08916939009087583

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  6 in total

1.  Prevention of adjuvant arthritis in rats by a nonapeptide from the 65-kD mycobacterial heat shock protein: specificity and mechanism.

Authors:  X D Yang; J Gasser; U Feige
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

Review 2.  The 65-kDa heat-shock protein in the pathogenesis, prevention and therapy of autoimmune arthritis and diabetes mellitus in rats and mice.

Authors:  U Feige; I R Cohen
Journal:  Springer Semin Immunopathol       Date:  1991

Review 3.  Heat shock proteins in autoimmune disease. From causative antigen to specific therapy?

Authors:  X D Yang; U Feige
Journal:  Experientia       Date:  1992-07-15

4.  Lack of protection in mice and necrotizing bronchointerstitial pneumonia with bronchiolitis in guinea pigs immunized with vaccines directed against the hsp60 molecule of Mycobacterium tuberculosis.

Authors:  O C Turner; A D Roberts; A A Frank; S W Phalen; D M McMurray; J Content; O Denis; S D'Souza; A Tanghe; K Huygen; I M Orme
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Proposing low-similarity peptide vaccines against Mycobacterium tuberculosis.

Authors:  Guglielmo Lucchese; Angela Stufano; Darja Kanduc
Journal:  J Biomed Biotechnol       Date:  2010-06-03

Review 6.  Heat shock proteins in immune response to cancer: the Fourth Paradigm.

Authors:  P K Srivastava
Journal:  Experientia       Date:  1994-11-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.